Sui‐Lin Mo

578 citations
12 papers · 406 indexed · h-index 9
Topics
Pharmacogenetics and Drug Metabolism (7 papers)Computational Drug Discovery Methods (3 papers)Drug Transport and Resistance Mechanisms (2 papers)
Journals
SHILAP Revista de lepidopterologíaActa Pharmaceutica Sinica BCurrent Drug Metabolism

In The Last Decade

Sui‐Lin Mo

12 papers receiving 404 citations

Peers

Sui‐Lin Mo
Comparison fields: 5 of 80
  • Pharmacology 191
  • Molecular Biology 152
  • Oncology 101
  • Complementary and alternative medicine 66
  • Pharmacology 58
Replace Shwu-Huey Liu with:
Shwu-Huey Liu United States
Elaine Lai Han Leung Macao
Teresa Tam Canada
Nadia Romiti Italy
Xiao-Xia Yang Singapore
Lieming Xu China
Xue‐Rong Xiao China
Lee Sun New Singapore
Sui‐Lin Mo relative to Shwu-Huey Liu United States Shwu-Huey Liu's profile →
Citations per field
00.5×1.5×
Shwu-Huey Liu · 1×
Citations per year

Countries citing papers authored by Sui‐Lin Mo

Since Specialization
Citations

This map shows the geographic impact of Sui‐Lin Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sui‐Lin Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sui‐Lin Mo more than expected).

Fields of papers citing papers by Sui‐Lin Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sui‐Lin Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sui‐Lin Mo. The network helps show where Sui‐Lin Mo may publish in the future.

Co-authorship network of co-authors of Sui‐Lin Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Sui‐Lin Mo. A scholar is included among the top collaborators of Sui‐Lin Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sui‐Lin Mo. Sui‐Lin Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 5
2 93
3 29
4 13
5 15
6 7
7 46
8 10
9 110
10 33
11 40
12
[Clinical observation on colquhounia root tablet in treating lipid metabolism disturbance secondary to nephrotic syndrome].
5

About Sui‐Lin Mo

Sui‐Lin Mo is a scholar working on Pharmacology, Complementary and alternative medicine and Biochemistry, having authored 12 papers that have together received 406 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Computational Drug Discovery Methods (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmacology (191 citations), Complementary and alternative medicine (66 citations) and Oncology (101 citations). Sui‐Lin Mo has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Wei Ming, Shu-Feng Zhou, Jagat R. Kanwar, Zhi-Wei Zhou, Shu-Feng Zhou, Zhiwei Zhou, Taoli Liu, Yue-Yu Gu, Heng Liu and Chun Guang Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Acta Pharmaceutica Sinica B and Current Drug Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026